An intravenous insulin protocol designed for pregnancy reduces neonatal hypoglycaemia following betamethasone administration in women with gestational diabetes.

Christopher W RoweE PuttO BrentnallA GebuehrJ AllabyrneA WoodsK Wynne

Published in: Diabetic medicine : a journal of the British Diabetic Association (2018)

An IVI protocol designed for pregnancy effectively controlled maternal hyperglycaemia following betamethasone administration in GDM. This is the first intervention to show a reduction in betamethasone-associated neonatal hypoglycaemia, linked with optimum maternal glycaemic control.

Keyphrases

pregnancy outcomes
type diabetes
randomized controlled trial
pregnant women
glycemic control
preterm birth
birth weight
high dose
insulin resistance
low dose
gestational age
weight gain
weight loss